Designing of pH-Sensitive Hydrogels for Colon Targeted Drug Delivery; Characterization and In Vitro Evaluation.

5-aminosalicylic acid chitosan drug release hydrogels β-cyclodextrin

Journal

Gels (Basel, Switzerland)
ISSN: 2310-2861
Titre abrégé: Gels
Pays: Switzerland
ID NLM: 101696925

Informations de publication

Date de publication:
03 Mar 2022
Historique:
received: 28 01 2022
revised: 14 02 2022
accepted: 21 02 2022
entrez: 24 3 2022
pubmed: 25 3 2022
medline: 25 3 2022
Statut: epublish

Résumé

In the current research work, pH-sensitive hydrogels were prepared via a free radical polymerization technique for the targeted delivery of 5-aminosalicylic acid to the colon. Various proportions of chitosan, β-Cyclodextrin, and acrylic acid were cross-linked by ethylene glycol dimethacrylate. Ammonium persulfate was employed as an initiator. The development of a new polymeric network and the successful encapsulation of the drug were confirmed by Fourier transform infrared spectroscopy. Thermogravimetric analysis indicated high thermal stability of the hydrogel compared to pure chitosan and β-Cyclodextrin. A rough and hard surface was revealed by scanning electron microscopy. Similarly, the crystallinity of the chitosan, β-Cyclodextrin, and fabricated hydrogel was evaluated using powder X-ray diffraction. The swelling and drug release studies were performed in both acidic and basic medium (pH 1.2 and 7.4, respectively) at 37 °C. High swelling and drug release was observed at pH 7.4 as compared to pH 1.2. The increased incorporation of chitosan, β-Cyclodextrin, and acrylic acid led to an increase in porosity, swelling, loading, drug release, and gel fraction of the hydrogel, whereas a decrease in sol fraction was observed. Thus, we can conclude from the results that a developed pH-sensitive network of hydrogel could be employed as a promising carrier for targeted drug delivery systems.

Identifiants

pubmed: 35323268
pii: gels8030155
doi: 10.3390/gels8030155
pmc: PMC8951511
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : National Science Council of Taiwan
ID : MOST 110-2320-B-037-014-MY2

Références

Front Chem. 2020 Feb 04;8:50
pubmed: 32117876
Colloids Surf B Biointerfaces. 2015 Jan 1;125:1-11
pubmed: 25460596
Carbohydr Polym. 2017 Jan 2;155:242-251
pubmed: 27702509
Pak J Pharm Sci. 2006 Apr;19(2):119-24
pubmed: 16751122
Daru. 2015 Aug 19;23:41
pubmed: 26283081
Biomaterials. 2006 Nov;27(31):5440-51
pubmed: 16828864
Ther Deliv. 2019 Nov;10(11):697-717
pubmed: 31789106
Polymers (Basel). 2021 Jul 27;13(15):
pubmed: 34372065
Colloids Surf B Biointerfaces. 2012 Jun 1;94:199-205
pubmed: 22341520
Int J Biol Macromol. 2020 Jun 1;152:437-448
pubmed: 32097742
Mater Sci Eng C Mater Biol Appl. 2016 Nov 1;68:251-257
pubmed: 27524019
Int J Biol Macromol. 2018 Dec;120(Pt B):1624-1631
pubmed: 30287359
Life Sci. 2021 Feb 15;267:118931
pubmed: 33359243
Clin Pharmacokinet. 1985 Jul-Aug;10(4):285-302
pubmed: 2864155
Int J Pharm. 2019 Mar 10;558:367-379
pubmed: 30664993
Int J Pharm. 2006 Nov 6;324(2):103-15
pubmed: 16824710
Colloids Surf B Biointerfaces. 2021 Aug;204:111819
pubmed: 33964528
Drug Des Devel Ther. 2017 Oct 24;11:3083-3096
pubmed: 29123380
Carbohydr Polym. 2016 Nov 20;153:203-211
pubmed: 27561488
Mater Sci Eng C Mater Biol Appl. 2021 Feb;119:111582
pubmed: 33321628
Carbohydr Polym. 2018 Feb 1;181:1169-1179
pubmed: 29253946
Eur J Pharm Biopharm. 2012 Jun;81(2):379-85
pubmed: 22386911
Biomaterials. 2007 Feb;28(6):1258-66
pubmed: 17118443
Int J Biol Macromol. 2015 Jan;72:1069-75
pubmed: 25312603
AAPS PharmSciTech. 2018 Oct;19(7):3199-3209
pubmed: 30171450
Int J Pharm. 2019 Feb 10;556:236-245
pubmed: 30553956
Mater Sci Eng C Mater Biol Appl. 2014 Nov;44:132-43
pubmed: 25280689
Int J Pharm. 2007 Sep 5;342(1-2):124-36
pubmed: 17590293
J Med Life. 2019 Apr-Jun;12(2):113-122
pubmed: 31406511
Curr Drug Deliv. 2018;15(9):1312-1322
pubmed: 29732987
Biomol Eng. 2007 Feb;24(1):131-9
pubmed: 16835016
Gels. 2017 Jan 24;3(1):
pubmed: 30920503
Carbohydr Polym. 2014 May 25;105:135-44
pubmed: 24708962

Auteurs

Muhammad Suhail (M)

School of Pharmacy, Kaohsiung Medical University, Kaohsiung City 80708, Taiwan.

Yu-Fang Shao (YF)

Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung City 80708, Taiwan.

Quoc Lam Vu (QL)

Department of Clinical Pharmacy, Thai Nguyen University of Medicine and Pharmacy, 284 Luong Ngoc Quyen Str., Thai Nguyen 24000, Vietnam.

Pao-Chu Wu (PC)

School of Pharmacy, Kaohsiung Medical University, Kaohsiung City 80708, Taiwan.
Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan.
Drug Development and Value Creation Research Center, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.

Classifications MeSH